FDA accepts BLA for CSL Behring’s prothrombin complex for warfarin reversal: http://finance.yahoo.com/news/csl-behring-announces-fda-filing-183300816.html The PR doesn’t give the PDUFA date but says the FDA is conducting a standard review.